Illinois CancerCare- Bloomington — Bloomington, Illinois

Illinois CancerCare- Bloomington is a clinical research site located in Bloomington, Illinois, United States 61704.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Illinois CancerCare- Bloomington has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, BRAF V600E-mutant Metastatic Colorectal Cancer, Non-small Cell Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare- Bloomington?

Illinois CancerCare- Bloomington has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare- Bloomington conducted?

Illinois CancerCare- Bloomington has 3 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, BRAF V600E-mutant Metastatic Colorectal Cancer, Non-small Cell Carcinoma.

Is Illinois CancerCare- Bloomington accredited by Crixeo Health?

Illinois CancerCare- Bloomington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare- Bloomington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.